Suppr超能文献

氢可酮-对乙酰氨基酚与曲马多对犬胫骨平台水平截骨术后疼痛控制的临床疗效

Clinical efficacy of hydrocodone-acetaminophen and tramadol for control of postoperative pain in dogs following tibial plateau leveling osteotomy.

作者信息

Benitez Marian E, Roush James K, McMurphy Rose, KuKanich Butch, Legallet Claire

出版信息

Am J Vet Res. 2015 Sep;76(9):755-62. doi: 10.2460/ajvr.76.9.755.

Abstract

OBJECTIVE

To evaluate clinical efficacy of hydrocodone-acetaminophen and tramadol for treatment of postoperative pain in dogs undergoing tibial plateau leveling osteotomy (TPLO). ANIMALS 50 client-owned dogs.

PROCEDURES

Standardized anesthetic and surgical protocols were followed. Each patient was randomly assigned to receive either tramadol hydrochloride (5 to 7 mg/kg, PO, q 8 h; tramadol group) or hydrocodone bitartrate-acetaminophen (0.5 to 0.6 mg of hydrocodone/kg, PO, q 8 h; hydrocodone group) for analgesia after surgery. The modified Glasgow composite measure pain scale was used to assess signs of postoperative pain at predetermined intervals by an investigator who was blinded to treatment group. Scoring commenced with the second dose of the assigned study analgesic. Pain scores and rates of treatment failure (ie, dogs requiring rescue analgesia according to a predetermined protocol) were compared statistically between groups.

RESULTS

12 of 42 (29%; 5/19 in the hydrocodone-acetaminophen group and 7/23 in the tramadol group) dogs required rescue analgesic treatment on the basis of pain scores. Median pain score for the hydrocodone group was significantly lower than that of the tramadol group 2 hours after the second dose of study analgesic. The 2 groups had similar pain scores at all other time points.

CONCLUSIONS AND CLINICAL RELEVANCE

Overall, differences in pain scores between dogs that received hydrocodone-acetaminophen or tramadol were minor. The percentage of dogs with treatment failure in both groups was considered unacceptable.

摘要

目的

评估氢可酮-对乙酰氨基酚和曲马多治疗接受胫骨平台水平截骨术(TPLO)的犬术后疼痛的临床疗效。动物 50 只客户拥有的犬。

程序

遵循标准化的麻醉和手术方案。每只患者被随机分配接受盐酸曲马多(5至7mg/kg,口服,每8小时一次;曲马多组)或酒石酸氢可酮-对乙酰氨基酚(0.5至0.6mg氢可酮/kg,口服,每8小时一次;氢可酮组)用于术后镇痛。由对治疗组不知情的研究者在预定时间间隔使用改良的格拉斯哥综合疼痛量表评估术后疼痛体征。评分从分配的研究镇痛药的第二剂开始。对两组之间的疼痛评分和治疗失败率(即根据预定方案需要解救镇痛的犬)进行统计学比较。

结果

42只犬中有12只(29%;氢可酮-对乙酰氨基酚组5/19,曲马多组7/23)基于疼痛评分需要解救镇痛治疗。在第二剂研究镇痛药后2小时,氢可酮组的中位疼痛评分显著低于曲马多组。在所有其他时间点,两组的疼痛评分相似。

结论及临床意义

总体而言,接受氢可酮-对乙酰氨基酚或曲马多的犬之间的疼痛评分差异较小。两组中治疗失败犬的百分比被认为不可接受。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验